Sundrug Co., Ltd. (SDGCF)
OTC
28.18
0.00 (0.00%)
Closed
Oct 8, 2026
Day's Range
28.1828.18
52 wk Range
28.1828.18
Financial Statements - SDGCF - Sundrug Co., Ltd.
Revenue
842.51B▲ 5.1%
Net Income
31.39B▲ 2.1%Net Margin 3.7%
EBITDA
65.36B▲ 6.7%
Free Cash Flow
12.16B▲ 76.3%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 842.51B | 801.81B | 5.09B | 690.46B | 648.73B | 634.31B |
| Cost of Goods | 626.34B | 597.72B | 3.80B | 518.51B | 492.22B | 475.76B |
| Gross Profit | 216.17B | 204.08B | 1.28B | 171.94B | 156.50B | 158.55B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 46.83B | 44.50B | 277.69M | 37.45B | 34.05B | 37.34B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 45.80B | 43.56B | 279.46M | 37.71B | 34.67B | 37.18B |
| Income Tax | 14.41B | 12.81B | 82.18M | 12B | 10.82B | 11.85B |
| Net Income | 31.39B | 30.75B | 197.27M | 25.70B | 23.85B | 25.32B |
| EPS Basic | 268.36 | 262.91 | 249.07 | 219.83 | 204.02 | 216.68 |
| EPS Diluted | 268.36 | 262.91 | 249.07 | 219.82 | 204.01 | 216.63 |
| Basic Shares Outstanding | 116.97M | 116.96M | 792.02K | 116.92M | 17.69B | 17.69B |
| Diluted Shares Outstanding | 116.97M | 116.96M | 792.02K | 116.92M | 17.69B | 17.69B |
| Ebit | 46.18B | 43.73B | 279.67M | 37.74B | 34.68B | 37.19B |
| Ebitda | 65.36B | 61.28B | 385.30M | 50.24B | 44.95B | 46.80B |
| Net Income Continuous Operations | 45.80B | 43.56B | 279.46M | 37.71B | 34.67B | 37.18B |
| Minority Interests | 0 | 0 | 0 | 0 | 0 | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
